BB&T Securities’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $684K | Buy |
6,993
+173
| +3% | +$19.5K | 0.01% | 967 |
|
|
2019
Q2 | $893K | Buy |
6,820
+561
| +9% | +$72.3K | 0.01% | 863 |
|
|
2019
Q1 | $846K | Buy |
6,259
+2,313
| +59% | +$288K | 0.01% | 871 |
|
|
2018
Q4 | $384K | Sell |
3,946
-684
| -15% | -$80.9K | ﹤0.01% | 1082 |
|
|
2018
Q3 | $643K | Buy |
4,630
+587
| +15% | +$73.6K | 0.01% | 977 |
|
|
2018
Q2 | $501K | Buy |
4,043
+404
| +11% | +$47.2K | 0.01% | 1080 |
|
|
2018
Q1 | $405K | Buy |
3,639
+248
| +7% | +$29.6K | ﹤0.01% | 1110 |
|
|
2017
Q4 | $405K | Buy |
3,391
+10
| +0.3% | +$1.22K | 0.01% | 1070 |
|
|
2017
Q3 | $474K | Buy |
3,381
+227
| +7% | +$30.8K | 0.01% | 988 |
|
|
2017
Q2 | $383K | Sell |
3,154
-4,279
| -58% | -$498K | 0.01% | 1061 |
|
|
2017
Q1 | $901K | Sell |
7,433
-4,501
| -38% | -$580K | 0.01% | 684 |
|
|
2016
Q4 | $1.46M | Hold |
11,934
| – | – | 0.02% | 519 |
|
|
2016
Q3 | $1.46M | Buy |
11,934
+3,402
| +40% | +$438K | 0.02% | 514 |
|
|
2016
Q2 | $996K | Buy |
8,532
+2,278
| +36% | +$323K | 0.02% | 602 |
|
|
2016
Q1 | $870K | Buy |
6,254
+438
| +8% | +$64.3K | 0.01% | 616 |
|
|
2015
Q4 | $1.11M | Buy |
5,816
+1,060
| +22% | +$185K | 0.02% | 503 |
|
|
2015
Q3 | $743K | Buy |
4,756
+690
| +17% | +$126K | 0.02% | 588 |
|
|
2015
Q2 | $735K | Buy |
4,066
+2,351
| +137% | +$406K | 0.02% | 615 |
|
|
2015
Q1 | $2.97M | Buy |
1,715
+311
| +22% | +$56.3K | 0.01% | 883 |
|
|
2014
Q4 | $2.6M | Buy |
+1,404
| New | +$260K | 0.01% | 937 |
|
|
2014
Q1 | – | Sell |
-1,609
| Closed | -$2.14M | – | 979 |
|
|
2013
Q4 | $2.14M | Buy |
+1,609
| New | +$193K | 0.01% | 823 |
|
Other funds holding ALXN
BBA
